[Highlights in hepatology].
This review highlights new treatment options in chronic hepatitis B, issues related to antiviral resistance and current recommendations for the monitoring of patients on treatment. We also discuss post-exposure prophylaxis of hepatitis A, treatment duration in chronic hepatitis C and recent studies exploring vaccination against hepatitis E and pioglitazone for nonalcoholic steatohepatitis. Finally, we will briefly comment new findings in alcoholic hepatitis as well as acetaminophen hepatotoxicity and summarize revised criteria for the diagnosis and management of hepatorenal syndrome.
Pache
Isabelle
I
Service de gastro-entérologie et d'hépatologie, CHUV, 1011 Lausanne. Isabelle.Pache@chuv.ch
Moradpour
Darius
D
D000998:Antiviral Agents / Q000627:therapeutic use*; D005762:Gastroenterology / Q000639:trends*; D006509:Hepatitis B / Q000188:drug therapy*; D019694:Hepatitis B, Chronic / Q000188:drug therapy; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic / Q000188:drug therapy
D000998:Antiviral Agents